Endocrinology
From the Journals
Autoimmune Diseases and Perinatal Depression May Share Two-Way Link
Study found women with autoimmune disease were 30% more likely to have perinatal depression. Risk was also 30% higher for the reverse scenario.
Feature
CMS Okays Payment for Novel AI Prostate Test
The test improves risk stratification or prognostication over standard clinical and pathologic tools, says expert.
From the Journals
Testosterone Replacement Therapy and Prostate Cancer Risk
New study suggests testosterone replacement therapy does not increase prostate cancer risk in men with hypogonadism.
From the Journals
Paget Disease of the Bone Progression Halted With Genetic Screening, Targeted Treatment
A single infusion of zoledronic acid substantially reduced existing bone lesions and biochemical markers of bone turnover over 7 years.
Latest News
Why GLP-1 Drugs Stop Working, and What to Do About It
If a patient plateaus on a GLP-1 drug, it may work to add additional drugs that have different brain targets.
From the Journals
Ozempic is Appealing, but Not Cost-Effective, for Obesity Treatment
Surgical and endoscopic options to treat obesity are cost effective, but not the pharmacological intervention semaglutide.
Latest News
Eli Lilly Offers Obesity Drug Directly to Consumers
Anti-obesity drug maker, Eli Lilly, to launch a direct-to-patient portal, allowing patients to obtain its drug for as low as $25 a month.
Feature
Evidence Grows for SGLT2 Inhibitors in Rheumatology
Sodium-glucose cotransporter-2 (SGLT2) inhibitors are not approved to treat gout, lupus, or lupus nephritis, but clinicians are uncovering signs...
Latest News
Pediatric Obesity Specialists Struggle to Get GLP-1s
Both liraglutide and semaglutide “are largely unavailable or quite hard to get a hold of.”
Opinion
JAMA Internal Medicine Editor Recaps 2023’s High-Impact Research
Harvard geriatrician Dr. Sharon K. Inouye highlights research into long COVID, thyroid levels, silicosis, and more.
Latest News
ED Visits for Diabetes on the Rise in the US
The most ED visits were made by patients with diabetes and two to four other chronic conditions.